Genetron Health Gains CE Mark for COVID-19 Test

Beijing-based Genetron Health has received a CE Mark for its novel coronavirus detection kit.

The polymerase chain-reaction test is designed for use with the company’s Genetron S5 sequencer for testing large-scale samples.

The company has also applied to the FDA for emergency use authorization.